Pictor is a leading in-vitro diagnostics company, specializing in the development of innovative diagnostic solutions for human and animal health. With their patented multiplexed platform, Pictor offers highly accurate and efficient testing for complex and infectious diseases. Their PictArray™ multiplexed technology allows for simultaneous analysis of multiple disease markers in a single test, providing higher sensitivity, faster throughput, and reduced turnaround time.

This breakthrough technology is revolutionizing infectious disease management. Since its inception in 2017, Pictor has grown rapidly, with over 30 employees across New Zealand, the USA, and India. Their multiplexed ToRCH diagnostic is currently utilized by over 400 laboratories in India for maternal infection screening.

Pictor is focused on commercializing its multiplexed technology platform, expanding its portfolio of diagnostic test panels, and bringing its products to new markets. With a strong commitment to quality and regulatory compliance, Pictor aims to serve the needs of clinical laboratories by providing innovative and cost-effective diagnostic products. Driven by their vision to be a global innovator in in-vitro diagnostics, Pictor is dedicated to reducing the global disease burden and improving health outcomes through the development and marketing of novel IVD products.

Explore their latest news releases for more information